Why Bother? Impact of Downstream Development and Market Considerations on Discovery Projects
Vince Wacher, PhD | Product Development and Planning
The ReFRAME Drug Repositioning Library: Building and Applications to Neglected Diseases
Arnab Chatterjee, PhD | VP Medicinal Chemistry | Calibr
Paving the Road to the Clinic: Advancing Oncology Drug Development with Translational In Vitro and In Vivo Models
Tommy Broudy, PhD | CEO | Molecular Response
BioDuro Solution Engine: Enabled Formulations Bridging Discovery and Development
Blair West, PhD | CSO, Global CMC Solutions | BioDuro
Reactive Melt Extrusion to Improve Properties of Amorphous Solid Dispersions
Feng Zhang, PhD | Assistant Professor of Pharmaceutics | University of Texas at Austin
Development of Poorly Soluble Compounds: Discovery to FIH and Later Clinical Development Phases
Hamid Rezai, PhD | Senior Director of Pharmaceutics | Plexxikon, Inc.
Requests for presentation copies can be made using the form below.
How can we accelerate successful drug discovery and development?
The success of clinical candidate development depends on several factors, important among them are generation of novel, therapeutically-relevant chemical structures, early and rapid assessment of possible efficacy of candidate structures in pre-clinical therapeutic models and rapid elimination of candidates that will ultimately prove unsuccessful. Innovative processes and techniques that facilitate optimal candidate selection is a crucial step in accelerating drug discovery and development timelines.
DATE AND TIME:
Thursday, June 14, 2018
11:30 AM – 6:30 PM PDT
Farmer & the Seahorse
10996 Torreyana Road
San Diego, CA 92121
11:30 PM- 12:30 PM
12:30 PM- 5:15 PM
Networking Happy Hour
5:15 PM- 6:30 PM